This inventor holds 1 USPTO granted patent. Top assignee: Universitè Laval. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: The Innovative Contributions of Denis Thibeault
Introduction
Denis Thibeault is a notable inventor based in Ste-Foy, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of anti-tumor compounds. His work is characterized by a focus on innovative solutions to combat cancer.
Latest Patents
Denis Thibeault holds a patent for the invention titled "Coupling of an anti-tumor to an antibody using glutaraldehyde." This invention relates to antitumor compounds that can effectively target malignant cells. The patent describes compounds of a specific formula wherein M can be a hydrogen atom, a peptide residue, or a protein residue linked to a carbon atom via the amino residue of epsilon-lysine. The antitumor agents mentioned include daunorubicin, doxorubicin, or an epirubicin derivative.
Career Highlights
Denis Thibeault is affiliated with Université Laval, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of how to effectively deliver anti-tumor agents to cancer cells. With a focus on practical applications, his research aims to improve treatment outcomes for patients.
Collaborations
Denis Thibeault has collaborated with Michel Page, enhancing the research efforts in their field. Their partnership has fostered innovation and has led to advancements in cancer treatment methodologies.
Conclusion
Denis Thibeault's contributions to the field of biotechnology, particularly through his patent on anti-tumor compounds, highlight his commitment to improving cancer treatment. His work at Université Laval and collaborations with fellow researchers underscore the importance of innovation in the fight against cancer.